Skip to content

Clinical trials

Completed Carcinoma, Hepatocellular trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Completed Country / region: Singapore Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20064
20071
20082
20095
20101
20112
20122
20137
20143
20153
20163
20172
20182
20195
20201
20211
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer9
National Cancer Centre, Singapore7
Bristol-Myers Squibb6
Hoffmann-La Roche6
AstraZeneca2
Light Sciences Oncology2
National Medical Research Council (NMRC), Singapore2
Novartis Pharmaceuticals2
Arbutus Biopharma Corporation1
Biogen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular50
Liver Neoplasms18
Carcinoma, Non-Small-Cell Lung4
Neoplasms4
Carcinoma, Renal Cell3
Carcinoma2
Liver Diseases2
Adenocarcinoma1
Adenoma1
Adenoma, Islet Cell1

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.